Top

Published in:

01-05-2014 | Diabetes and Cardiovascular Disease (S Malik, Section Editor)

Diabetes and Associated Complications in the South Asian Population

Authors: Arti Shah, Alka M. Kanaya

Published in: Current Cardiology Reports | Issue 5/2014

Abstract

The rising prevalence of diabetes in South Asians has significant health and economic implications. South Asians are predisposed to the development of diabetes due to biologic causes which are exacerbated by lifestyle and environmental factors. Furthermore, they experience significant morbidity and mortality from complications of diabetes, most notably coronary artery disease, cerebrovascular disease, and chronic kidney disease. Therefore, understanding the pathophysiology and genetics of diabetes risk factors and its associated complications in South Asians is paramount to curbing the diabetes epidemic. With this understanding, the appropriate screening, preventative and therapeutic strategies can be implemented and further developed. In this review, we discuss in detail the biologic and lifestyle factors that predispose South Asians to diabetes and review the epidemiology and pathophysiology of microvascular and macrovascular complications of diabetes in South Asians. We also review the ongoing and completed diabetes prevention and management studies in South Asians.

Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14.PubMed

Lee JW, Brancati FL, Yeh HC. Trends in the prevalence of type 2 diabetes in Asians versus Whites: Results from the United States National Health Interview Survey, 1997-2008. Diabetes Care. 2011;34(2):353–7.PubMedCentralPubMed

Misra R, Patel T, Kotha P, et al. Prevalence of diabetes, metabolic syndrome, and cardiovascular risk factors in US Asian Indians: Results from a national study. J Diabetes Complicat. 2010;24(3):145–53.PubMed

Mohan V. Why are Indians more prone to diabetes? J Assoc Physicians India. 2004;52:468–74.PubMed

Chan JC, Malik V, Jia W, et al. Diabetes in Asia: Epidemiology, risk factors, and pathophysiology. JAMA. 2009;301(20):2129–40.PubMed

Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia. Lancet. 2010;375(9712):408–18.PubMed

Chowdhury TA, Lasker SS. Complications and cardiovascular risk factors in South Asians and Europeans with early-onset type 2 diabetes. QJM. 2002;95(4):241–6.PubMed

Swerdlow AJ, Laing SP, Dos Santos SI, et al. Mortality of South Asian patients with insulin-treated diabetes mellitus in the United Kingdom: A cohort study. Diabet Med. 2004;21(8):845–51.PubMed

Mather HM, Chaturvedi N, Fuller JH. Mortality and morbidity from diabetes in South Asians and Europeans: 11-year follow-up of the Southall Diabetes Survey, London, UK. Diabet Med. 1998;15(1):53–9.

10.

Mohan V, Sharp PS, Cloke HR, Burrin JM, Schumer B, Kohner EM. Serum immunoreactive insulin responses to a glucose load in Asian Indian and European type 2 (non-insulin-dependent) diabetic patients and control subjects. Diabetologia. 1986;29(4):235–7.PubMed

11.

Hu FB. Globalization of diabetes: The role of diet, lifestyle, and genes. Diabetes Care. 2011;34(6):1249–57.PubMedCentralPubMed

12.

Bavdekar A, Yajnik CS, Fall CH, et al. Insulin resistance syndrome in 8-year-old Indian children: Small at birth, big at 8 years, or both? Diabetes. 1999;48(12):2422–9.PubMed

13.

Ramachandran A, Snehalatha C, Yamuna A, Murugesan N, Narayan KM. Insulin resistance and clustering of cardiometabolic risk factors in urban teenagers in southern India. Diabetes Care. 2007;30(7):1828–33.PubMed

14.

Scholfield DJ, Behall KM, Bhathena SJ, Kelsay J, Reiser S, Revett KR. A study on Asian Indian and American vegetarians: Indications of a racial predisposition to glucose intolerance. Am J Clin Nutr. 1987;46(6):955–61.PubMed

15.

Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab. 1999;84(7):2329–35.PubMed

16.

Petersen KF, Dufour S, Feng J, et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci U S A. 2006;103(48):18273–7.PubMedCentralPubMed

17.

Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia. 2003;46(1):3–19.PubMed

18.

Motala AA, Omar MA. Evidence for impaired pancreatic beta cell function in South African Indians with impaired glucose tolerance. Diabet Med. 1994;11(5):437–44.PubMed

19.

Staimez LR, Weber MB, Ranjani H, et al. Evidence of reduced beta-cell function in Asian Indians with mild dysglycemia. Diabetes Care. 2013;36(9):2772–8.PubMed

20.

Deurenberg-Yap M, Schmidt G, van Staveren WA, Deurenberg P. The paradox of low body mass index and high body fat percentage among Chinese, Malays and Indians in Singapore. Int J Obes Relat Metab Disord. 2000;24(8):1011–7.PubMed

21.

Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ, Birmingham CL. Visceral adipose tissue accumulation differs according to ethnic background: Results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr. 2007;86(2):353–9.PubMed

22.

Sharp PS, Mohan V, Levy JC, Mather HM, Kohner EM. Insulin resistance in patients of Asian Indian and European origin with non-insulin dependent diabetes. Horm Metab Res. 1987;19(2):84–5.PubMed

23.

Yajnik CS, Fall CH, Coyaji KJ, et al. Neonatal anthropometry: The thin-fat Indian baby. The Pune Maternal Nutrition Study. Int J Obes Relat Metab Disord. 2003;27(2):173–80.

24.

Krishnaveni GV, Hill JC, Veena SR, et al. Truncal adiposity is present at birth and in early childhood in South Iindian children. Indian Pediatr. 2005;42(6):527–38.

25.

Bhargava SK, Sachdev HS, Fall CH, et al. Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med. 2004;350(9):865–75.PubMedCentralPubMed

26.

McKeigue PM, Pierpoint T, Ferrie JE, Marmot MG. Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in South Asians and Europeans. Diabetologia. 1992;35(8):785–91.PubMed

27.

Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab. 1999;84(1):137–44.PubMed

28.

Raji A, Seely EW, Arky RA, Simonson DC. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab. 2001;86(11):5366–71.PubMed

29.

Sandeep S, Gokulakrishnan K, Velmurugan K, Deepa M, Mohan V. Visceral & subcutaneous abdominal fat in relation to insulin resistance & metabolic syndrome in non-diabetic South Indians. Indian J Med Res. 2010;131:629–35.PubMed

30.

Indulekha K, Anjana RM, Surendar J, Mohan V. Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113). Clin Biochem. 2011;44(4):281–7.PubMed

31.

Chandalia M, Lin P, Seenivasan T, et al. Insulin resistance and body fat distribution in South Asian men compared to Caucasian men. PLoS One. 2007;2(8):e812.

32.

Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: More than just another fat cell hormone? Diabetes Care. 2003;26(8):2442–50.PubMed

33.

Abate N, Chandalia M, Snell PG, Grundy SM. Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men. J Clin Endocrinol Metab. 2004;89(6):2750–5.PubMed

34.

Wasim H, Al-Daghri NM, Chetty R, McTernan PG, Barnett AH, Kumar S. Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in South-Asians. Cardiovasc Diabetol. 2006;5:10.

35.

Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol Med. 2008;14(11–12):741–51.PubMedCentralPubMed

36.

Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286(3):327–34.PubMed

37.

Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336(14):973–9.PubMed

38.

Forouhi NG, Sattar N, McKeigue PM. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord. 2001;25(9):1327–31.PubMed

39.

Chambers JC, Eda S, Bassett P, et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation. 2001;104(2):145–50.PubMed

40.

Chandalia M, Cabo-Chan Jr AV, Devaraj S, Jialal I, Grundy SM, Abate N. Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States. J Clin Endocrinol Metab. 2003;88(8):3773–6.PubMed

41.

Mohan V, Deepa R, Velmurugan K, Premalatha G. Association of C-reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: The Chennai Urban Rural Epidemiology Study (CURES-6). Diabet Med. 2005;22(7):863–70.PubMed

42.

Gujral UP, Pradeepa R, Weber MB, Narayan KM, Mohan V. Type 2 diabetes in South Asians: Similarities and differences with white Caucasian and other populations. Ann N Y Acad Sci. 2013;1281:51–63.PubMedCentralPubMed

43.

Kooner JS, Saleheen D, Sim X, et al. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet. 2011;43(10):984–9.PubMedCentralPubMed

44.

Chambers JC, Elliott P, Zabaneh D, et al. Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat Genet. 2008;40(6):716–8.PubMed

45.

Abate N, Carulli L, Cabo-Chan Jr A, Chandalia M, Snell PG, Grundy SM. Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance. J Clin Endocrinol Metab. 2003;88(12):5927–34.PubMed

46.

Vaidya A, Williams JS. Vitamin D and insulin sensitivity: Can gene association and pharmacogenetic studies of the vitamin D receptor provide clarity? Metabolism. 2012;61(6):759–61.PubMed

47.

Sanghera DK, Ortega L, Han S, et al. Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. BMC Med Genet. 2008;9:59-2350-9-59.

48.

Chauhan G, Spurgeon CJ, Tabassum R, et al. Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the risk of type 2 diabetes in 5,164 Indians. Diabetes. 2010;59(8):2068–74.PubMedCentralPubMed

49.

Rees SD, Hydrie MZ, Shera AS, et al. Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia. 2011;54(6):1368–74.PubMed

50.

Sanghera DK, Demirci FY, Been L, et al. PPARG and ADIPOQ gene polymorphisms increase type 2 diabetes mellitus risk in Asian Indian Sikhs: Pro12Ala still remains as the strongest predictor. Metabolism. 2010;59(4):492–501.PubMedCentralPubMed

51.

Humphries SE, Gable D, Cooper JA, et al. Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European whites, Indian Asians and Afro-Caribbean men and women. J Mol Med (Berl). 2006;84(12):1005–14.

52.

Tan JT, Nurbaya S, Gardner D, Ye S, Tai ES, Ng DP. Genetic variation in KCNQ1 associates with fasting glucose and beta-cell function: A study of 3,734 subjects comprising three ethnicities living in Singapore. Diabetes. 2009;58(6):1445–9.PubMedCentralPubMed

53.

Been LF, Ralhan S, Wander GS, et al. Variants in KCNQ1 increase type II diabetes susceptibility in South Asians: A study of 3,310 subjects from India and the US. BMC Med Genet. 2011;12:18-2350-12-18.

54.

Sanghera DK, Been L, Ortega L, et al. Testing the association of novel meta-analysis-derived diabetes risk genes with type II diabetes and related metabolic traits in Asian Indian Sikhs. J Hum Genet. 2009;54(3):162–8.PubMed

55.

Chauhan G, Tabassum R, Mahajan A, et al. Common variants of FTO and the risk of obesity and type 2 diabetes in Indians. J Hum Genet. 2011;56(10):720–6.PubMed

56.

Ramya K, Radha V, Ghosh S, Majumder PP, Mohan V. Genetic variations in the FTO gene are associated with type 2 diabetes and obesity in South Indians (CURES-79). Diabetes Technol Ther. 2011;13(1):33–42.

57.

Yajnik CS, Janipalli CS, Bhaskar S, et al. FTO gene variants are strongly associated with type 2 diabetes in South Asian Indians. Diabetologia. 2009;52(2):247–52.

58.

Vasan SK, Fall T, Neville MJ, et al. Associations of variants in FTO and near MC4R with obesity traits in South Asian Indians. Obesity (Silver Spring). 2012;20(11):2268–77.

59.

Rees SD, Islam M, Hydrie MZ, et al. An FTO variant is associated with type 2 diabetes in South Asian populations after accounting for body mass index and waist circumference. Diabet Med. 2011;28(6):673–80.PubMedCentralPubMed

60.

Radha V, Vimaleswaran KS, Ayyappa KA, Mohan V. Association of lipoprotein lipase gene polymorphisms with obesity and type 2 diabetes in an Asian Indian population. Int J Obes (Lond). 2007;31(6):913–8.

61.

Cassell PG, Saker PJ, Huxtable SJ, et al. Evidence that single nucleotide polymorphism in the uncoupling protein 3 (UCP3) gene influences fat distribution in women of European and Asian origin. Diabetologia. 2000;43(12):1558–64.PubMed

62.

Bhagat N, Agrawal M, Luthra K, Vikram NK, Misra A, Gupta R. Evaluation of single nucleotide polymorphisms of Pro12Ala in peroxisome proliferator-activated receptor-gamma and Gly308Ala in tumor necrosis factor-alpha genes in obese Asian Indians: A population-based study. Diabetes Metab Syndr Obes. 2010;3:349–56.PubMedCentralPubMed

63.

Qi L, Tai ES, Tan CE, et al. Intragenic linkage disequilibrium structure of the human perilipin gene (PLIN) and haplotype association with increased obesity risk in a multiethnic Asian population. J Mol Med (Berl). 2005;83(6):448–56.

64.

Shen H, Qi L, Tai ES, Chew SK, Tan CE, Ordovas JM. Uncoupling protein 2 promoter polymorphism -866G/A, central adiposity, and metabolic syndrome in Asians. Obesity (Silver Spring). 2006;14(4):656–61.

65.

Guettier JM, Georgopoulos A, Tsai MY, et al. Polymorphisms in the fatty acid-binding protein 2 and apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian population. J Clin Endocrinol Metab. 2005;90(3):1705–11.

66.

Vimaleswaran KS, Radha V, Mohan V. Thr54 allele carriers of the Ala54Thr variant of FABP2 gene have associations with metabolic syndrome and hypertriglyceridemia in urban South Indians. Metabolism. 2006;55(9):1222–6.PubMed

67.

Dodani S, Henkhaus R, Dong L, Butler MG. Apolipoprotein A1 gene polymorphisms predict cardio-metabolic risk in South Asian immigrants. Dis Markers. 2012;32(1):9–19.PubMedCentralPubMed

68.

Ranjith N, Pegoraro RJ, Rom L. Lipid profiles and associated gene polymorphisms in young Asian Indian patients with acute myocardial infarction and the metabolic syndrome. Metab Syndr Relat Disord. 2009;7(6):571–8.PubMed

69.

Vimaleswaran KS, Radha V, Ghosh S, et al. Peroxisome proliferator-activated receptor-gamma co-activator-1alpha (PGC-1alpha) gene polymorphisms and their relationship to type 2 diabetes in Asian Indians. Diabet Med. 2005;22(11):1516–21.PubMed

70.•

Anand SS, Meyre D, Pare G, et al. Genetic information and the prediction of incident type 2 diabetes in a high-risk multiethnic population: The EpiDREAM genetic study. Diabetes Care. 2013;36(9):2836–42. This study investigated the role of a gene score (using 16 polymorphisms known to be associated with diabetes) in predicting incident diabetes. They looked at several ethnic groups, including South Asians. PubMed

71.

Ramachandran A, Mary S, Yamuna A, Murugesan N, Snehalatha C. High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India. Diabetes Care. 2008;31(5):893–8.PubMed

72.

Singh RB, Ghosh S, Niaz AM, et al. Epidemiologic study of diet and coronary risk factors in relation to central obesity and insulin levels in rural and urban populations of North India. Int J Cardiol. 1995;47(3):245–55.PubMed

73.

Ramachandran A, Snehalatha C, Latha E, Manoharan M, Vijay V. Impacts of urbanisation on the lifestyle and on the prevalence of diabetes in native Asian Indian population. Diabetes Res Clin Pract. 1999;44(3):207–13.PubMed

74.

Abate N, Chandalia M. Ethnicity, type 2 diabetes & migrant Asian Indians. Indian J Med Res. 2007;125(3):251–8.PubMed

75.

Mohanty SA, Woolhandler S, Himmelstein DU, Bor DH. Diabetes and cardiovascular disease among Asian Indians in the United States. J Gen Intern Med. 2005;20(5):474–8.PubMedCentralPubMed

76.

Patel JV, Vyas A, Cruickshank JK, et al. Impact of migration on coronary heart disease risk factors: Comparison of Gujaratis in Britain and their contemporaries in villages of origin in India. Atherosclerosis. 2006;185(2):297–306.

77.

Misra A, Khurana L, Isharwal S, Bhardwaj S. South Asian diets and insulin resistance. Br J Nutr. 2009;101(4):465–73.PubMed

78.

Raj S, Ganganna P, Bowering J. Dietary habits of Asian Indians in relation to length of residence in the United States. J Am Diet Assoc. 1999;99(9):1106–8.PubMed

79.

Wandel M, Raberg M, Kumar B, Holmboe-Ottesen G. Changes in food habits after migration among South Asians settled in Oslo: The effect of demographic, socio-economic and integration factors. Appetite. 2008;50(2–3):376–85.PubMed

80.

Garduno-Diaz SD, Khokhar S. Prevalence, risk factors and complications associated with type 2 diabetes in migrant South Asians. Diabetes Metab Res Rev. 2012;28(1):6–24.PubMed

81.

Helmrich SP, Ragland DR, Leung RW, Paffenbarger Jr RS. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med. 1991;325(3):147–52.PubMed

82.

Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.PubMed

83.

Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537–44.PubMed

84.

Fischbacher CM, Hunt S, Alexander L. How physically active are South Asians in the United Kingdom? A literature review. J Public Health (Oxf). 2004;26(3):250–8.

85.

Mohan V, Gokulakrishnan K, Deepa R, Shanthirani CS, Datta M. Association of physical inactivity with components of metabolic syndrome and coronary artery disease–the Chennai Urban Population Study (CUPS no. 15). Diabet Med. 2005;22(9):1206–11.PubMed

86.

Hayes L, White M, Unwin N, et al. Patterns of physical activity and relationship with risk markers for cardiovascular disease and diabetes in Indian, Pakistani, Bangladeshi and European adults in a UK population. J Public Health Med. 2002;24(3):170–8.PubMed

87.

Kanaya AM, Wassel CL, Mathur D, et al. Prevalence and correlates of diabetes in South Asian Indians in the United States: Findings from the Metabolic Syndrome and Atherosclerosis in South Asians Living in America Study and the Multi-Ethnic Study of Atherosclerosis. Metab Syndr Relat Disord. 2010;8(2):157–64.

88.

Tillin T, Hughes AD, Mayet J, et al. The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans: SABRE (Southall and Brent revisited) – a prospective population-based study. J Am Coll Cardiol. 2013;61(17):1777–86.PubMedCentralPubMed

89.

Ethnicity and cardiovascular disease. The incidence of myocardial infarction in white, South Asian, and Afro-Caribbean patients with type 2 diabetes (U.K. Prospective Diabetes Study 32). Diabetes Care. 1998;21(8):1271-1277.

90.•

Kanaya AM, Adler N, Moffet HH, et al. Heterogeneity of diabetes outcomes among Asians and Pacific Islanders in the US: The Diabetes Study of Northern California (DISTANCE). Diabetes Care. 2011;34(4):930–7. This paper discusses ethnic differences in complications of diabetes in a large northern California population, focusing specifically on the large differences among different Asian American populations. PubMedCentralPubMed

91.

Forouhi NG, Sattar N, Tillin T, McKeigue PM, Chaturvedi N. Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? Prospective follow-up of the Southall and Brent studies, UK. Diabetologia. 2006;49(11):2580–8.PubMed

92.

Wilkinson P, Sayer J, Laji K, et al. Comparison of case fatality in South Asian and white patients after acute myocardial infarction: Observational study. BMJ. 1996;312(7042):1330–3.PubMedCentralPubMed

93.

Nijjar AP, Wang H, Dasgupta K, Rabi DM, Quan H, Khan NA. Outcomes in a diabetic population of South Asians and whites following hospitalization for acute myocardial infarction: A retrospective cohort study. Cardiovasc Diabetol. 2010;9:4-2840-9-4.

94.

Game FL, Jones AF. Ethnicity and risk factors for coronary heart disease in diabetes mellitus. Diabetes Obes Metab. 2000;2(2):91–7.PubMed

95.

Barnett AH, Dixon AN, Bellary S, et al. Type 2 diabetes and cardiovascular risk in the UK South Asian community. Diabetologia. 2006;49(10):2234–46.PubMed

96.

Deepa R, Mohan V, Premanand C, et al. Accelerated platelet activation in Asian Indians with diabetes and coronary artery disease–the Chennai Urban Population Study (CUPS-13). J Assoc Physicians India. 2006;54:704–8.PubMed

97.

Bhaskar S, Ganesan M, Chandak GR, et al. Association of PON1 and APOA5 gene polymorphisms in a cohort of Indian patients having coronary artery disease with and without type 2 diabetes. Genet Test Mol Biomarkers. 2011;15(7–8):507–12.PubMed

98.

Siezenga MA, Shaw PK, Daha MR, Rabelink TJ, Berger SP. Low mannose-binding lectin (MBL) genotype is associated with future cardiovascular events in type 2 diabetic South Asians. A prospective cohort study. Cardiovasc Diabetol. 2011;10:60-2840-10-60.

99.

Narne P, Ponnaluri KC, Singh S, Siraj M, Ishaq M. Relationship between NADPH oxidase p22phox C242T, PARP-1 Val762Ala polymorphisms, angiographically verified coronary artery disease and myocardial infarction in South Indian patients with type 2 diabetes mellitus. Thromb Res. 2012;130(5):e259–65.

100.

Gunarathne A, Patel JV, Gammon B, Gill PS, Hughes EA, Lip GY. Ischemic stroke in South Asians: A review of the epidemiology, pathophysiology, and ethnicity-related clinical features. Stroke. 2009;40(6):e415–23.PubMed

101.

Moussouttas M, Aguilar L, Fuentes K, et al. Cerebrovascular disease among patients from the Indian subcontinent. Neurology. 2006;67(5):894–6.PubMed

102.

Jafar TH. Blood pressure, diabetes, and increased dietary salt associated with stroke–results from a community-based study in Pakistan. J Hum Hypertens. 2006;20(1):83–5.PubMed

103.

Deleu D, Hamad AA, Kamram S, El Siddig A, Al Hail H, Hamdy SM. Ethnic variations in risk factor profile, pattern and recurrence of non-cardioembolic ischemic stroke. Arch Med Res. 2006;37(5):655–62.PubMed

104.

Gholap N, Davies M, Patel K, Sattar N, Khunti K. Type 2 diabetes and cardiovascular disease in South Asians. Prim Care Diabetes. 2011;5(1):45–56.PubMed

105.

Gunarathne A, Patel JV, Potluri R, et al. Increased 5-year mortality in the migrant South Asian stroke patients with diabetes mellitus in the United Kingdom: The West Birmingham Stroke Project. Int J Clin Pract. 2008;62(2):197–201.PubMed

106.

Gerstein HC, Anand S, Yi QL, et al. The relationship between dysglycemia and atherosclerosis in South Asian, Chinese, and European individuals in Canada: A randomly sampled cross-sectional study. Diabetes Care. 2003;26(1):144–9.PubMed

107.

Venkataraman V, Amutha A, Anbalagan VP, et al. Association of glycated hemoglobin with carotid intimal medial thickness in Asian Indians with normal glucose tolerance. J Diabetes Complicat. 2012;26(6):526–30.PubMed

108.

Chow CK, McQuillan B, Raju PK, et al. Greater adverse effects of cholesterol and diabetes on carotid intima-media thickness in South Asian Indians: Comparison of risk factor-IMT associations in two population-based surveys. Atherosclerosis. 2008;199(1):116–22.

109.

Kelemen LE, Anand SS, Hegele RA, et al. Associations of plasma homocysteine and the methylenetetrahydrofolate reductase C677T polymorphism with carotid intima media thickness among South Asian, Chinese and European Canadians. Atherosclerosis. 2004;176(2):361–70.PubMed

110.

Gunarathne A, Patel JV, Kausar S, Gammon B, Hughes EA, Lip GY. Glycemic status underlies increased arterial stiffness and impaired endothelial function in migrant South Asian stroke survivors compared to European Caucasians: Pathophysiological insights from The West Birmingham Stroke Project. Stroke. 2009;40(7):2298–306.PubMed

111.

Kain K, Catto AJ, Grant PJ. Clustering of thrombotic factors with insulin resistance in South Asian patients with ischaemic stroke. Thromb Haemost. 2002;88(6):950–3.

112.

Kain K, Brockway M, Ishfaq T, et al. Ankle pressures in UK South Asians with diabetes mellitus: A case control study. Heart. 2013;99(9):614–9.PubMed

113.

Premalatha G, Shanthirani S, Deepa R, Markovitz J, Mohan V. Prevalence and risk factors of peripheral vascular disease in a selected South Indian population: The Chennai Urban Population Study. Diabetes Care. 2000;23(9):1295–300.PubMed

114.

Bennett PC, Silverman S, Gill PS, Lip GY. Ethnicity and peripheral artery disease. QJM. 2009;102(1):3–16.PubMed

115.

Chaturvedi N, Coady E, Mayet J, et al. Indian Asian men have less peripheral arterial disease than European men for equivalent levels of coronary disease. Atherosclerosis. 2007;193(1):204–12.PubMed

116.

Chaturvedi N, Abbott CA, Whalley A, Widdows P, Leggetter SY, Boulton AJ. Risk of diabetes-related amputation in South Asians vs. Europeans in the UK. Diabet Med. 2002;19(2):99–104.PubMed

117.

Abbott CA, Garrow AP, Carrington AL, et al. Foot ulcer risk is lower in South-Asian and African-Caribbean compared with European diabetic patients in the U.K.: The Northwest Diabetes Foot Care Study. Diabetes Care. 2005;28(8):1869–75.PubMed

118.

Stolk RP, van Schooneveld MJ, Cruickshank JK, et al. Retinal vascular lesions in patients of Caucasian and Asian origin with type 2 diabetes: Baseline results from the ADVANCE retinal measurements (AdRem) study. Diabetes Care. 2008;31(4):708–13.PubMed

119.

Sivaprasad S, Gupta B, Gulliford MC, et al. Ethnic variations in the prevalence of diabetic retinopathy in people with diabetes attending screening in the United Kingdom (DRIVE UK). PLoS One. 2012;7(3):e32182.PubMedCentralPubMed

120.

Pardhan S, Gilchrist J, Mahomed I. Impact of age and duration on sight-threatening retinopathy in South Asians and Caucasians attending a diabetic clinic. Eye (Lond). 2004;18(3):233–40.

121.

Raymond NT, Varadhan L, Reynold DR, et al. Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with white Europeans in the community: A cross-sectional study. Diabetes Care. 2009;32(3):410–5.PubMedCentralPubMed

122.

Sivaprasad S, Gupta B, Gulliford MC, et al. Ethnic variation in the prevalence of visual impairment in people attending diabetic retinopathy screening in the United Kingdom (DRIVE UK). PLoS One. 2012;7(6):e39608.PubMedCentralPubMed

123.

Pradeepa R, Anitha B, Mohan V, Ganesan A, Rema M. Risk factors for diabetic retinopathy in a South Indian type 2 diabetic population–the Chennai Urban Rural Epidemiology Study (CURES) Eye Study 4. Diabet Med. 2008;25(5):536–42.PubMed

124.

Uthra S, Raman R, Mukesh BN, et al. Diabetic retinopathy and IGF-1 gene polymorphic cytosine-adenine repeats in a Southern Indian cohort. Ophthalmic Res. 2007;39(5):294–9.PubMed

125.

Uthra S, Raman R, Mukesh BN, et al. Intron 4 VNTR of endothelial nitric oxide synthase (eNOS) gene and diabetic retinopathy in type 2 patients in Southern India. Ophthalmic Genet. 2007;28(2):77–81.PubMed

126.

Uthra S, Raman R, Mukesh BN, et al. Association of VEGF gene polymorphisms with diabetic retinopathy in a South Indian cohort. Ophthalmic Genet. 2008;29(1):11–5.PubMed

127.

Uthra S, Raman R, Mukesh BN, et al. Diabetic retinopathy: Validation study of ALR2, RAGE, iNOS and TNFB gene variants in a South Indian cohort. Ophthalmic Genet. 2010;31(4):244–51.PubMed

128.

Prasad P, Tiwari AK, Kumar KM, et al. Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms. BMC Med Genet. 2006;7:42.PubMedCentralPubMed

129.

Dixon AN, Raymond NT, Mughal S, et al. Prevalence of microalbuminuria and hypertension in South Asians and white Europeans with type 2 diabetes: A report from the United Kingdom Asian Diabetes Study (UKADS). Diab Vasc Dis Res. 2006;3(1):22–5.

130.

Burden AC, McNally PG, Feehally J, Walls J. Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom. Diabet Med. 1992;9(7):641–5.PubMed

131.

Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population. JAMA. 2002;287(19):2519–27.PubMed

132.

Roderick PJ, Raleigh VS, Hallam L, Mallick NP. The need and demand for renal replacement therapy in ethnic minorities in England. J Epidemiol Community Health. 1996;50(3):334–9.PubMedCentralPubMed

133.

Mather HM, Chaturvedi N, Kehely AM. Comparison of prevalence and risk factors for microalbuminuria in South Asians and Europeans with type 2 diabetes mellitus. Diabet Med. 1998;15(8):672–7.PubMed

134.

Dreyer G, Hull S, Aitken Z, Chesser A, Yaqoob MM. The effect of ethnicity on the prevalence of diabetes and associated chronic kidney disease. QJM. 2009;102(4):261–9.PubMed

135.

Chandie Shaw PK, Baboe F, van Es LA, et al. South-Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch-European diabetic patients. Diabetes Care. 2006;29(6):1383–5.PubMed

136.

Chandie Shaw PK, Vandenbroucke JP, Tjandra YI, et al. Increased end-stage diabetic nephropathy in Indo-Asian immigrants living in the Netherlands. Diabetologia. 2002;45(3):337–41.PubMed

137.

Shah VN, Cheema BS, Sharma R, et al. ACAC-β gene (rs2268388) and AGTR1 gene (rs5186) polymorphism and the risk of nephropathy in Asian Indian patients with type 2 diabetes. Mol Cell Biochem. 2013;372(1–2):191–8.PubMed

138.

Prasad P, Tiwari AK, Kumar KM, et al. Association of TGF-β-1, TNF-α, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians. BMC Med Genet. 2007;8:20.PubMedCentralPubMed

139.

Ahluwalia TS, Khullar M, Ahuja M, et al. Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians. PLoS One. 2009;4(4):e5168.PubMedCentralPubMed

140.

Prasad P, Kumar KM, Ammini AC, Gupta A, Gupta R, Thelma BK. Association of dopaminergic pathway gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes. BMC Genet. 2008;9:26-2156-9-26.

141.

Tiwari AK, Prasad P, B KT, et al. Oxidative stress pathway genes and chronic renal insufficiency in Asian Indians with type 2 diabetes. J Diabetes Complicat. 2009;23(2):102–11.PubMed

142.

Prasad P, Tiwari AK, Kumar KM, et al. Association analysis of ADPRT1, AKR1B1, RAGE, GFPT2 and PAI-1 gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes. BMC Med Genet. 2010;11:52-2350-11-52.

143.

Mooyaart AL, van Valkengoed IG, Shaw PK, et al. Lower frequency of the 5/5 homozygous CNDP1 genotype in South Asian Surinamese. Diabetes Res Clin Pract. 2009;85(3):272–8.PubMed

144.

Ashok S, Ramu M, Deepa R, Mohan V. Prevalence of neuropathy in type 2 diabetic patients attending a diabetes centre in South India. J Assoc Physicians India. 2002;50:546–50.

145.

Pradeepa R, Rema M, Vignesh J, Deepa M, Deepa R, Mohan V. Prevalence and risk factors for diabetic neuropathy in an urban South Indian population: The Chennai Urban Rural Epidemiology Study (CURES-55). Diabet Med. 2008;25(4):407–12.PubMed

146.

UK Prospective Diabetes Study. XII: Differences between Asian, Afro-Caribbean and white Caucasian type 2 diabetic patients at diagnosis of diabetes. UK Prospective Diabetes Study group. Diabet Med. 1994;11(7):670-677.

147.

Abbott CA, Chaturvedi N, Malik RA, et al. Explanations for the lower rates of diabetic neuropathy in Indian Asians versus Europeans. Diabetes Care. 2010;33(6):1325–30.PubMedCentralPubMed

148.

Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care. 2011;34(10):2220–4.PubMedCentralPubMed

149.

Gujral JS, McNally PG, O'Malley BP, Burden AC. Ethnic differences in the incidence of lower extremity amputation secondary to diabetes mellitus. Diabet Med. 1993;10(3):271–4.PubMed

150.

http://www.diabetes.org/diabetes-basics/prevention/diabetes-risk-test/.

151.

Lindstrom J, Tuomilehto J. The diabetes risk score: A practical tool to predict type 2 diabetes risk. Diabetes Care. 2003;26(3):725–31.PubMed

152.••

Mohan V, Anbalagan VP. Expanding role of the Madras Diabetes Research Foundation - Indian Diabetes Risk Score in clinical practice. Indian J Endocrinol Metab. 2013;17(1):31–6. This paper discusses the role of a diabetes risk score that was developed and validated in a South Asian population and reviews it myriad applications. PubMedCentralPubMed

153.

Joshi SR. Indian diabetes risk score. J Assoc Physicians India. 2005;53:755–7.PubMed

154.

Ramachandran A, Snehalatha C, Mary S, et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49(2):289–97.PubMed

155.

Snehalatha C, Mary S, Selvam S, et al. Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1). Diabetes Care. 2009;32(10):1796–801.PubMedCentralPubMed

156.

Ramachandran A, Snehalatha C, Mary S, et al. Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in asian indians: Results of the Indian Diabetes Prevention Programme-2 (IDPP-2). Diabetologia. 2009;52(6):1019–26.

157.

DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators, Gerstein HC, Yusuf S, et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet. 2006;368(9541):1096–105.PubMed

158.

Bellary S, O'Hare JP, Raymond NT, et al. Enhanced diabetes care to patients of South Asian ethnic origin (The United Kingdom Asian Diabetes Study): A cluster randomised controlled trial. Lancet. 2008;371(9626):1769–76.

159.

Narayan V. National Institutes of Health. A randomized trial of diabetes prevention through lifestyles changes in India (D-CLIP). http://clinicaltrials.gov/ct2/show/NCT01283308. Updated 30 March 2012.

160.

Douglas A, Bhopal RS, Bhopal R, et al. Design and baseline characteristics of the PODOSA (Prevention of Diabetes & Obesity in South Asians) trial: A cluster, randomised lifestyle intervention in Indian and Pakistani adults with impaired glycaemia at high risk of developing type 2 diabetes. BMJ Open. 2013;3(2):e002226. doi:10.1136/bmjopen-2012-002226.PubMedCentralPubMed

161.

Narayan V. National Institutes of Health. A Culturally tailored lifestyle intervention to prevent diabetes in South Asians (SHAPE). http://clinicaltrials.gov/ct2/show/NCT01084928. Updated 30 March 2012.

Title: Diabetes and Associated Complications in the South Asian Population
Authors: Arti Shah
Alka M. Kanaya
Publication date: 01-05-2014
Publisher: Springer US
Published in: Current Cardiology Reports / Issue 5/2014
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-014-0476-5

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Diabetes and Associated Complications in the South Asian Population

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2014

Intracranial Hemorrhage and Novel Anticoagulants for Atrial Fibrillation: What Have We Learned?

Current Status and Future Perspectives on Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

The Global Burden of Cardiovascular Diseases: A Challenge to Improve

CFR and FFR Assessment with PET and CTA: Strengths and Limitations

“East Asian Paradox”: Challenge for the Current Antiplatelet Strategy of “One-Guideline-Fits-All Races” in Acute Coronary Syndrome

4D Flow Imaging: Current Status to Future Clinical Applications

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page